ethanolamine has been researched along with Pregnancy in 14 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the serum levels of IgG and IgM anticardiolipin (ACL), anti-beta-2-glycoprotein I (B2GPI), anti-phosphatidyl serine (PS), anti-prothrombin(PT), anti-annexin V (AnV) and anti-ethanolamine (Eth) antibodies using an ELISA method (Orgentec, Germany) in 16 females with normal pregnancy in the I, II and Ill trimester." | 3.79 | [Antibodies against phospholipids in patients with normal pregnancy]. ( Baleva, M; Karagjozova, Zh; Tchernev, T, 2013) |
"Fetal intervention is indicated if hydrops fetalis develops." | 1.38 | Treatment of congenital pulmonary airway malformation induced hydrops fetalis via percutaneous sclerotherapy. ( Chmait, RH; Grikscheit, TC; Lee, FL; Llanes, A; Said, N; Shin, CE, 2012) |
"Gestational diabetes is a metabolic disorder affecting 2-5% of women and is a predictor of obesity, Type 2 diabetes mellitus and cardiovascular disease." | 1.32 | Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. ( Crawford, MA; Ghebremeskel, K; Lowy, C; Min, Y; Thomas, B, 2004) |
" Thus, it was concluded that MEA was not developmentally toxic to Wistar rats following repeated oral administration, even at maternally toxic dose levels as high as 450 mg/kg/day." | 1.30 | Evaluation of the pre-, peri-, and postnatal toxicity of monoethanolamine in rats following repeated oral administration during organogenesis. ( Hellwig, J; Liberacki, AB, 1997) |
" Thus, it was concluded that MEA was not developmentally toxic following dermal application at exposure levels up to and including 225 mg/kg/day for rats and 75 mg/kg/day for rabbits." | 1.29 | Evaluation of the developmental toxicity of dermally applied monoethanolamine in rats and rabbits. ( Breslin, WJ; Liberacki, AB; Neeper-Bradley, TL; Zielke, GJ, 1996) |
"Ethanolamine was given by gavage at levels of 0, 500, 300, or 50 mg/kg/day (24%, 14." | 1.27 | Studies on the embryopathic effects of ethanolamine in Long-Evans rats: preferential embryopathy in pups contiguous with male siblings in utero. ( Mankes, RF, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moore, NP | 1 |
Wahl, M | 1 |
Schneider, S | 1 |
Karagjozova, Zh | 1 |
Tchernev, T | 1 |
Baleva, M | 1 |
Kako, K | 1 |
Nakamura, A | 1 |
Nagashima, Y | 1 |
Ishida, J | 1 |
Fukamizu, A | 1 |
Lee, FL | 1 |
Said, N | 1 |
Grikscheit, TC | 1 |
Shin, CE | 1 |
Llanes, A | 1 |
Chmait, RH | 1 |
Min, Y | 1 |
Ghebremeskel, K | 2 |
Lowy, C | 1 |
Thomas, B | 1 |
Crawford, MA | 2 |
Jain, S | 1 |
Jayasimhulu, K | 1 |
Clark, JF | 1 |
Bitsanis, D | 1 |
Moodley, T | 1 |
Djahanbakhch, O | 1 |
Kume, H | 1 |
Sasaki, H | 1 |
Kano-Sueoka, T | 1 |
Sooranna, SR | 1 |
Burston, D | 1 |
Ramsay, B | 1 |
Steer, PJ | 1 |
Liberacki, AB | 2 |
Neeper-Bradley, TL | 1 |
Breslin, WJ | 1 |
Zielke, GJ | 1 |
Hellwig, J | 1 |
Micanovic, R | 1 |
Gerber, LD | 1 |
Berger, J | 1 |
Kodukula, K | 1 |
Udenfriend, S | 1 |
O'Keefe, EJ | 1 |
Payne, RE | 1 |
Russell, N | 1 |
Mankes, RF | 1 |
14 other studies available for ethanolamine and Pregnancy
Article | Year |
---|---|
Implantation loss induced by ethanolamine in the rat is ameliorated by a choline-supplemented diet.
Topics: Animals; Choline; Dietary Supplements; Embryo Implantation; Ethanolamine; Female; Male; Pregnancy; R | 2018 |
[Antibodies against phospholipids in patients with normal pregnancy].
Topics: Annexin A5; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; beta 2-Glycoprotein I; Ethano | 2013 |
Detection of ethanolamine altering in fetuses of pregnancy-associated hypertensive mice treated with vasodepressors by using UPLC and MALDI-TOF/MS.
Topics: Animals; Antihypertensive Agents; Chromatography, High Pressure Liquid; Ethanolamine; Female; Fetus; | 2015 |
Treatment of congenital pulmonary airway malformation induced hydrops fetalis via percutaneous sclerotherapy.
Topics: Adult; Cystic Adenomatoid Malformation of Lung, Congenital; Ethanolamine; Female; Gestational Age; H | 2012 |
Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes.
Topics: Adult; Arachidonic Acid; Choline; Diabetes Mellitus; Diabetes, Gestational; Docosahexaenoic Acids; E | 2004 |
Metabolomic analysis of molecular species of phospholipids from normotensive and preeclamptic human placenta electrospray ionization mass spectrometry.
Topics: Arachidonic Acids; Chromatography; Chromatography, Thin Layer; Ethanolamine; Fatty Acids, Nonesterif | 2004 |
Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids.
Topics: Adult; Arachidonic Acid; Case-Control Studies; Diabetes, Gestational; Docosahexaenoic Acids; Ethanol | 2006 |
Serum ethanolamine and hepatocyte proliferation in perinatal and partially hepatectomized rats.
Topics: Animals; Cell Proliferation; Ethanolamine; Female; Hepatectomy; Hepatocytes; Liver; Liver Regenerati | 2006 |
Free amino acid concentrations in human first and third trimester placental villi.
Topics: Alkaline Phosphatase; Amino Acids; Aminobutyrates; Arginine; Chorionic Villi; Ethanolamine; Ethanola | 1994 |
Evaluation of the developmental toxicity of dermally applied monoethanolamine in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Administration, Topical; Animals; Embryonic and Fetal Development; Etha | 1996 |
Evaluation of the pre-, peri-, and postnatal toxicity of monoethanolamine in rats following repeated oral administration during organogenesis.
Topics: Animals; Animals, Newborn; Body Weight; Embryonic and Fetal Development; Ethanolamine; Female; Growt | 1997 |
Selectivity of the cleavage/attachment site of phosphatidylinositol-glycan-anchored membrane proteins determined by site-specific mutagenesis at Asp-484 of placental alkaline phosphatase.
Topics: Alkaline Phosphatase; Amino Acid Sequence; Animals; Aspartic Acid; Bromelains; Cell Line; Ethanolami | 1990 |
Keratinocyte growth-promoting activity from human placenta.
Topics: Cell Count; Cell Division; Culture Media; Dialysis; Epidermal Cells; Epidermal Growth Factor; Ethano | 1985 |
Studies on the embryopathic effects of ethanolamine in Long-Evans rats: preferential embryopathy in pups contiguous with male siblings in utero.
Topics: Animals; Dose-Response Relationship, Drug; Ethanolamine; Ethanolamines; Female; Fetal Death; Fetal G | 1986 |